Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:669819rdf:typepubmed:Citationlld:pubmed
pubmed-article:669819lifeskim:mentionsumls-concept:C0029347lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C0597363lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C0042960lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C1549078lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C1997894lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C1551074lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C1553024lld:lifeskim
pubmed-article:669819lifeskim:mentionsumls-concept:C0042645lld:lifeskim
pubmed-article:669819pubmed:issue3lld:pubmed
pubmed-article:669819pubmed:dateCreated1978-9-30lld:pubmed
pubmed-article:669819pubmed:abstractTextThe Hong Kong/68-ts-1[E] virus and its Udorn/72 and Georgia/74 recombinants, which have a 38 degrees C shutoff temperature and a ts lesion(s) on the genes coding for the P3 and NP proteins, were adequately attenuated and immunogenic in adult volunteers who lacked serum hemagglutination-inhibiting antibody (titer, </=1:8), but who possessed serum neuraminidase-inhibiting antibody. Two Victoria/75-ts-1[E] clones that also had a 38 degrees C shutoff temperature and a ts lesion(s) on the same two genes were administered to adult volunteers who lacked both serum hemagglutination-inhibiting antibody (titer, </=1:8) and neuraminidase-inhibiting antibody (titer, </=1:4). In contrast to the behavior of the earlier ts-1[E] recombinants, the Vic/75-ts-1[E] recombinants retained the capacity to cause febrile, systemic illness. However, the recombinants were attenuated compared with wild-type virus. The Vic/75-ts-1[E] virus vaccinees shed a larger amount of virus for a longer time than the previous ts-1[E] vaccinees, but they shed less virus than volunteers infected with wild-type virus. The ts-1[E] virus shed retained its ts phenotype in most instances and failed to spread to susceptible contacts. Vaccinees were partially protected against homologous wild-type virus challenge. The failure of HK/68, Udorn/72, and Georgia/74 ts-1[E] vaccinees to develop systemic reactions may reflect the presence of neuraminidase immunity before infection. In this situation, attenuation probably resulted from the degree of defectiveness of the ts-1[E] recombinant virus and the existence of neuraminidase immunity in the recipients. The 50% human infectious dose of the Vic/75 ts-1[E] virus was less than 10(5.2) 50% tissue culture infective doses. This suggests that at the time of a pandemic shift involving both the hemagglutinin and neuraminidase glycoproteins, a small amount of live virus vaccine might be effective in initiating infection.lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:languageenglld:pubmed
pubmed-article:669819pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:citationSubsetIMlld:pubmed
pubmed-article:669819pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:669819pubmed:statusMEDLINElld:pubmed
pubmed-article:669819pubmed:monthJunlld:pubmed
pubmed-article:669819pubmed:issn0019-9567lld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:LevineM MMMlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:ChanockR MRMlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:DouglasR GRGlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:KendalA PAPlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:CouchR BRBlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:WatermanD HDHlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:MurphyB RBRlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:BettsR FRFlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:CateT RTRJrlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:HolleyH PHPJrlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:MarkoffL JLJlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:HosierN TNTlld:pubmed
pubmed-article:669819pubmed:authorpubmed-author:RusselI IIIlld:pubmed
pubmed-article:669819pubmed:issnTypePrintlld:pubmed
pubmed-article:669819pubmed:volume20lld:pubmed
pubmed-article:669819pubmed:ownerNLMlld:pubmed
pubmed-article:669819pubmed:authorsCompleteYlld:pubmed
pubmed-article:669819pubmed:pagination671-7lld:pubmed
pubmed-article:669819pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-H...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-M...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-I...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-N...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-R...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-G...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-A...lld:pubmed
pubmed-article:669819pubmed:meshHeadingpubmed-meshheading:669819-H...lld:pubmed
pubmed-article:669819pubmed:year1978lld:pubmed
pubmed-article:669819pubmed:articleTitleTemperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers.lld:pubmed
pubmed-article:669819pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:669819pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:669819lld:pubmed